BIIB

NASD Biogen Inc.
Sep 29, 2026 · 4:12 AM ET EOD Market Closed

$228.69 ↑ +0.00 (+0.00%) Trading Up from the previous close of $228.69, $1.80 below the day’s high of $230.49

YTD change
+29.94%
vs 20-day SMA
+4.31%
vs 200-day SMA
+17.91%

Price ranges

Previous day
$225.51 $230.49
open $225.87 close $228.69
+$2.82 (+1.25%)
Today
$225.51 $230.49
$228.69
Past week
$214.59 $229.19
from $215.50 now $228.69
+$13.19 (+6.12%)
Past month
$208.93 $229.19
from $221.50 now $228.69
+$7.19 (+3.25%)
This year
$160.37 $230.49
from $175.99 now $228.69
+$52.70 (+29.94%)

Price & Performance

+41.12 (+21.92%) / 6M

$167.83$189.62$211.41$233.20Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 51.2% away from all-time highs of $468.55
  • BIIB is up 30% since the beginning of the year
  • BIIB is up 66% over the past 12 months
  • BIIB is up 3% over the past 1 month
  • 4% of all BIIB investors are betting against BIIB

BIIB reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +65.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.6
Earnings momentum -77.4% Quarterly EPS growth
Quarterly change -77.4%

Valuation

P/E ratio 40.21
Enterprise value $40.9B
Beta 0.37

Balance sheet & scale

Income$834.6K
Revenue$9.7B
Cash$1.3B
Debt$8.4M
Income / Debt 0.10×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $33.8B

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.78 +0.11%
JNJ Johnson & Johnson $271.95 +0.27%
ABBV AbbVie, Inc. $266.28 +0.73%
MRK Merck & Co., Inc. $148.69 -0.06%
RHHVF Roche Holding Ltd $444.62 -0.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.